Abstract
Zeynab Kavyani a b 1 , Erfan shahhosseini c 1 , Amir Hossein Moridpour a , Maryam Falahatzadeh d , Mahdi Vajdi e , Vali Musazadeh a b , Gholamreza Askari f
Abstract
Background
Aim of the review
Methods
Results
Conclusion
The results of our study revealed that the supplementation of berberine could be effective in improving WC, and lipid profile, although the impact of this supplement on obesity indices needs further investigation.
Mahsa Rounagh a 1 , Vali Musazadeh b 1 , Ali Hosseininejad-Mohebati c , Maryam Falahatzadeh d , Zeynab Kavyani g , Reza Bijan Rostami e , Mahdi Vajdi f
Summary
Background and aim
Methods
Results
Conclusion
Bastani, Peivand; Marzaleh, Milad Ahmadi1; Dehghani, Mina1; Falahatzadeh, Maryam2; Rahmati, Elahe1; Tahernezhad, Ali3
Abstract
Due to the increasing elderly population and the subsequent increase in their need for medication and more referrals to the pharmacy, this study was conducted to investigate the Iranian hospital pharmacies in terms of age-friendliness criteria. This was a cross-sectional study conducted in 2017. The study population included 3 metropolitan hospital pharmacies selected through clustered sampling, and all their 67 pharmacies were included by census. Data collection tool was a reliable researcher-made checklist (t = 0.85, α = 0.9) Data analysis was performed using Kruskal–Wallis test and Mann–Whitney test through SPSS version 24. The results in these three cities showed that only two pharmacies were in a high level of age-friendly. The relationship between type of pharmacy and the final score of age-friendly situation in these cities showed no significant relationship. There was no significant relationship among the average of the final score of the age-friendly situation in three studied cities. Due to the increasing elderly population and the aging society, readiness of Iranian hospital pharmacies to provide services to the elderly will be one of the most challenging issues in the long term. With proper legislation and policies on health-care systems, especially pharmacies, physical and psychological problems in elderly can be reduced in the future. Furthermore, with advancing toward age-friendly pharmacies, the community can be empower and become ready encountering elderly problems.
Shabnam Shirvani a 1 , Maryam Falahatzadeh b 1 , Elham Oveili c , Mehrdad Jamali d , Pedram Pam d , Maryam Parang e , Mehrnaz Shakarami f
Abstract
Soroor Fathi a , Soheil Agharloo a , Maryam Falahatzadeh b , Sara Bahraminavid c , Ali Homayooni d , Amir Hossein Faghfouri e , Daniel Shafiei f , Seyyed-Ghavam Shafagh g
Summary
Background and aim
Methods
Results
Conclusion
Maryam Falahatzadeh a , Kianoosh Najafi b , Kaveh Bashti c
Abstract
The Effect of Glucomannan Supplementation on Lipid Profile in Adults
Authors: Vali Musazadeh, Rogheye Yaraee Rostami, Amir Hossein Moridpour, Zahra Bokaii Hosseini, Omid Nikpayam, Maryam Falahatzadeh & Amir Hossein Faghfouri
688 Accesses | 5 Altmetric | 1 Mention
Abstract
Background: Glucomannan has been studied for various health benefits, but its effects on lipid profile in adults are not well understood. This meta-analysis aims to evaluate the impact of glucomannan supplementation on serum/plasma levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), Apo B1, Apo A1, APO-B/ A1 ratio, and LDL-C/ HDL-C in adults.
Methods: A comprehensive search was conducted across Scopus, PubMed, Embase, and Web of Science from inception to June 2024 to identify randomized controlled trials (RCTs) assessing glucomannan supplementation on lipid profile in adults. Data were extracted and analyzed using random effects model to determine the standardized mean differences (SMDs) and 95% confidence intervals (CIs) for each biomarker.
Results: Glucomannan supplementation significantly decreased TC (SMD: -3.299; 95% CI: -4.955, -1.664, P < 0.001; I 2 = 95.41%, P-heterogeneity < 0.001), LDL-C (SMD: -2.993; 95% CI: -4.958, -1.028; P = 0.006; I 2 = 95.49%, P-heterogeneity < 0.001), and Apo B1 (SMD: -2.2; 95% CI: -3.58, -0.82; P = 0.01). However, glucomannan did not alter the levels of TG (SMD: -0.119; 95% CI: -1.076, 0.837, P = 0.789; I 2 = 91.63%, P-heterogeneity < 0.001), Apo A1 (SMD: -0.48; 95% CI: -6.27, 5.32; P = 0.76), APO-B/ A1 ratio (SMD: -1.15; 95% CI: -2.91, 0.61; P = 0.11), and LDL-C/ HDL-C ratio (SMD: -2.2; 95% CI: -7.28, 2.87; P = 0.2).
Conclusions: Glucomannan supplementation has a beneficial effect on the level of TC and LDL-C.